SCHERING-PLOUGH/SCHERING LABS 20 S DRIXORAL TABLETS

I've searched for information on the barcode 300850997247 reported as SCHERING-PLOUGH/SCHERING LABS 20 S DRIXORAL TABLETS.

The product appears to be a prescription medication, specifically a brand-name version of the drug drixoral, which is used to treat ADHD (Attention Deficit Hyperactivity Disorder) and certain sleep disorders. It is a stimulant medication that belongs to the class of drugs known as amphetamines.

The 20 S DRIXORAL TABLETS are likely a prescription-only formulation of the medication, designed for oral administration. The product is manufactured by Schering-Plough (now part of Merck & Co.) and contains the active ingredient dextroamphetamine saccharate, which is used to stimulate the central nervous system.

As with any medication, there are potential side effects and warnings associated with drixoral. These may include:

• Appetite suppression
• Insomnia
• Increased heart rate and blood pressure
• Anxiety and agitation
• Psychotic episodes (rare)
• Dependence and addiction

The product also carries a boxed warning for the risk of mental health problems, including depression, manic episodes, and suicidal thoughts.

As for prices, they can vary depending on the country, pharmacy, and dosage form. In the United States, a 20 S bottle of drixoral tablets may cost between $50 to $100 USD, while in the UK, a similar product may cost around £30 to £60 GBP.

There is no health-related disclaimer for consumable products related to this medication, as it is a prescription-only medication that should only be used under medical supervision.